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Abstract
Background: Plantar heel pain is one of the most common musculoskeletal disorders of the foot
and ankle. Treatment of the condition is usually conservative, however the effectiveness of many
treatments frequently used in clinical practice, including supportive taping of the foot, has not been
established. We performed a participant-blinded randomised trial to assess the effectiveness of
low-Dye taping, a commonly used short-term treatment for plantar heel pain.
Methods: Ninety-two participants with plantar heel pain (mean age 50 ± 14 years; mean body mass
index 30 ± 6; and median self-reported duration of symptoms 10 months, range of 2 to 240
months) were recruited from the general public between February and June 2005. Participants
were randomly allocated to (i) low-Dye taping and sham ultrasound or (ii) sham ultrasound alone.
The duration of follow-up for each participant was one week. No participants were lost to follow-
up. Outcome measures included 'first-step' pain (measured on a 100 mm Visual Analogue Scale)
and the Foot Health Status Questionnaire domains of foot pain, foot function and general foot
health.
Results: Participants treated with low-Dye taping reported a small improvement in 'first-step' pain
after one week of treatment compared to those who did not receive taping. The estimate of effect
on 'first-step' pain favoured the low-Dye tape (ANCOVA adjusted mean difference -12.3 mm; 95%
CI -22.4 to -2.2; P = 0.017). There were no other statistically significant differences between groups.
Thirteen participants in the taping group experienced an adverse event however most were mild
to moderate and short-lived.
Conclusion: When used for the short-term treatment of plantar heel pain, low-Dye taping
provides a small improvement in 'first-step' pain compared with a sham intervention after a one-
week period.
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Background
Plantar heel pain (plantar fasciitis) can be a painful and
debilitating condition. It is a common disorder in both
athletic [1] and sedentary populations [2-4]. A recent
United States study estimated that each year one million
patient visits at office-based physicians and hospital out-
patient departments are for the diagnosis and treatment of
heel pain[5]. Seven percent of adults aged 65 years or
older have been found to have plantar heel pain[2,3]. The
disorder is thought to be multifactorial in origin with fac-
tors such as obesity, excessive periods of weightbearing
activity and decreased ankle range of motion commonly
suggested to be involved [6].
A wide variety of management strategies have been devel-
oped to treat the disorder. A systematic review [7] identi-
fied 26 different conservative treatments that have been
recommended for the treatment of plantar heel pain.
Only heel pads, orthoses, steroid injections, night splints
and extracorporeal shock wave therapy have been evalu-
ated in randomised trials.
Foot orthoses are a common treatment for plantar heel
pain, however due to the manufacturing process, they
often require a period of a few weeks between the initial
consultation and issuing the devices. As such, short-term
treatments such as supportive taping are used to alleviate
symptoms during this interim period[8] – the low-Dye [9]
taping technique being one of the most frequently used. A
systematic review[10] of randomised crossover trials
examined the effect of low-Dye taping on biomechanical
variables. Like foot orthoses, it is thought that supportive
tape reduces the symptoms of plantar heel pain by reduc-
ing strain in the plantar fascia during standing and ambu-
lation [11]. A reduction in strain is achieved by reducing
navicular drop upon weightbearing (i.e. arch col-
lapse)[10]. However, it is unknown if a change in a surro-
gate outcome measure such as navicular drop actually
correlates to an improvement for the patient.
To this date, the effect of low-Dye taping on patient out-
comes has only been assessed in non-randomised trials
with beneficial results reported[12,13]. We therefore con-
ducted a participant-blinded randomised trial to deter-
mine whether low-Dye taping is an effective short-term
treatment for plantar heel pain.
Methods
A randomised, participant-blinded trial was conducted
between February and June 2005. Participants with a clin-
ical diagnosis of plantar heel pain and who provided
informed consent were randomly allocated to one of two
groups: (i) low-Dye taping with sham ultrasound, or (ii)
sham ultrasound only. Participants were informed prior
to entering the study that a sham intervention was being
administered in the trial and were blinded as to whether
they were receiving active treatment or not. Ethical
approval for the trial was gained from the University of
Western Sydney Human Research Ethics Committee. The
trial was registered with the Australian Clinical Trials Reg-
istry (ACTRN012605000046606) which meets the
requirements of the International Committee of Medical
Journal Editors (ICMJE) for trial registration [14].
Participants
Participants were included if diagnosed with plantar heel
pain described as (i) a localised pain at the plantar heel;
(ii) that was worst when first standing or walking after
rest; and (iii) that improved initially after first standing
but worsened with increasing activity. Participants also
needed to be ≥ 18 years of age and have had experienced
symptoms for ≥ four weeks. Participants were excluded
from the trial if they had any inflammatory, osseous, met-
abolic or neurological abnormalities or had received a
corticosteroid injection within the past three months. Par-
ticipants with known tape allergies were also excluded.
Participants were encouraged not to commence use of any
new treatments during the trial (e.g. anti-inflammatory
medication, foot orthoses etc.).
Clinical protocol
Participants were recruited from local community news-
paper advertisements in Campbelltown (Sydney, Aus-
tralia) and treated at a university podiatry clinic. The
random allocation sequence was generated using a com-
puter program (Microsoft Excel) in one block (i.e. simple
randomisation). The allocation sequence was concealed
from the researcher (JR) enrolling and assessing partici-
pants in sequentially numbered, opaque, sealed and sta-
pled envelopes. Aluminium foil inside the envelope was
used to render the envelope impermeable to intense light.
To prevent subversion of the allocation sequence, the
name and date of birth of the participant was written on
the envelope and a video tape made of the sealed enve-
lope with participant details visible. Carbon paper inside
the envelope transferred the information onto the alloca-
tion card inside the envelope and a second researcher
(CC) later viewed video tapes to ensure envelopes were
still sealed when participants' names were written on
them. Corresponding envelopes were opened only after
the enrolled participants completed all baseline assess-
ments and it was time to allocate the intervention.
Three minutes of sham ultrasound (Accusonic AS250,
Metron) was then given to the painful heel regardless of
whether participants had been allocated the active inter-
vention (i.e. tape) or not. The ultrasound unit was pow-
ered with all operational lights activated. At
commencement of treatment the researcher (JR) turned
up the wattage of the machine which was accompanied byBMC Musculoskeletal Disorders 2006, 7:64 http://www.biomedcentral.com/1471-2474/7/64
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'beeping' sounds. However, no ultrasound was emitted as
the internal timer was not activated; an external timer was
used instead.
Participants in the taping group were then taped using the
low-Dye taping technique[13] (participants allocated the
sham treatment did not receive tape). The skin was first
swabbed with alcohol and then Leuko® Spray Adhesive
(Beiersdorf Australasia Ltd) was sprayed on the foot to
assist tape adhesion. Low-Dye taping was then sequen-
tially applied using Leuko® Premium Plus (flesh coloured)
Sports Tape 3.8 cm wide (Beiersdorf Australasia Ltd.). The
technique used (Figure 1) has been described in detail
elsewhere[13]. Tape required for one application cost
approximately AU$1.00. In the absence of adverse events,
participants allocated to taping were instructed to leave
the tape on until their follow-up appointment (one week
later). Care was taken that study participants did not meet
by ensuring they exited the building by a different door-
way to the one through which they entered.
Outcome assessment was performed at baseline and at
one week. Baseline variables that were collected included
age, sex, weight, self-reported hours on feet, duration of
symptoms, foot posture, ankle range of motion. Outcome
measures included: (i) 'first-step' pain – the pain experi-
enced when first standing after arising from bed in the
morning, measured on a 100 mm Visual Analogue Scale;
and (ii) the Foot Health Status Questionnaire which has
four domains covering foot pain, foot function, footwear
and general foot health (although we pre-specified that
we would not analyse the footwear domain). The Foot
Health Status Questionnaire – a self-rated health status
measure – has been previously validated (content, crite-
rion and construct validity) across a wide spectrum of
pathologies including skin, nail and musculoskeletal dis-
orders. It has a high test-retest reliability (intraclass corre-
lation coefficients ranging from 0.74 to 0.92) and a high
degree of internal consistency (Cronbach's α ranging from
0.85 to 0.88)[15]. To minimise the investigator having
influence on participant responses, participants com-
pleted the outcome assessments prior to each consulta-
tion.
Participants with bilateral symptoms only received treat-
ment for the foot with the worst symptoms and partici-
pants were asked to concentrate on the pain in that foot
when completing all outcome measures. Participants who
removed tape before returning were asked to concentrate
on the symptoms they had experienced while the tape was
on the foot. The number of days participants wore the
tape was recorded.
Sample size, data handling and analysis
The sample size of 92 (i.e. 46 per group) was calculated a
priori. This sample size provides an 80% probability of
detecting a minimal important difference [16] of 14
points between the groups on the pain domain of the Foot
Health Status Questionnaire (standard deviation 24 and
alpha level 0.05). This sample size also provided adequate
power to detect a minimal important difference of 9
points on the Visual Analogue Scale (standard deviation
15.5). We conservatively ignored the extra precision pro-
vided by covariate analysis when estimating sample size.
Outcome data were analysed by intention to treat and
according to a pre-planned protocol (i.e. a priori). To max-
imise precision of estimates, analysis of covariance
(ANCOVA) was conducted using a linear regression
approach[17,18]. The outcomes analysed were the change
in 'first-step' pain (Visual Analogue Scale) and the change
in foot pain, foot function and general foot health (Foot
Health Status Questionnaire). We pre-specified that the
baseline outcome measure (i.e. 'first-step' pain or Foot
Health Status Questionnaire data at baseline) would be
used as the only covariate in each analysis[19]. For the
Low-Dye taping Figure 1
Low-Dye taping.BMC Musculoskeletal Disorders 2006, 7:64 http://www.biomedcentral.com/1471-2474/7/64
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analysis of 'first-step' pain we adjusted for 'first-step' pain
at baseline. For the analysis of Foot Health Status Ques-
tionnaire foot pain, foot function and general foot health
we adjusted for these domains at baseline. Independent
researchers (not otherwise involved in the trial – see
acknowledgments) performed data entry and were
blinded to group allocation. Double data entry was used
to check for errors. Statistical analyses were performed
while researchers were blinded to group allocation.
An independent sample t-test was used to determine if
there was a difference between groups in the number of
days between baseline and follow-up appointments. Par-
ticipants were also asked which intervention (active or
sham) they thought they had received and an index[20]
calculated to assess the success of blinding. The index
takes the value 1 for complete blinding and 0 for complete
lack of blinding; 0.5 is the equivalent of random guessing.
Results
Baseline characteristics (Table 1) between groups were
similar in all outcomes, although the taping group had a
higher percentage of bilateral cases than the sham group
(63% to 48%). Participants were primarily middle-aged
(mean 50 years; SD ± 14), female (55 women; 60%), over-
weight (BMI mean 30; SD ± 6); spent the majority of the
day on their feet (mean 8 hours; SD ± 3) and presented
with relatively chronic pain (median 10 months, range 2
to 240).
Figure 2 displays the flow of participants through the trial.
There were no participants lost to follow-up. There was no
difference between the groups in time to follow-up (p =
0.378). From baseline to the review appointment the
mean number of days was 7.2 days (SD ± 0.7) for the tap-
ing group and 7.2 days (SD ± 0.6) for the placebo group.
Participants in the taping group left the tape on for a
median of 7 days (range 3 to 9 days).
Both the taping and sham groups improved in 'first-step'
pain, foot pain and foot function at follow-up (Table 2).
Only for 'first-step' pain did the taping group experience a
greater improvement compared to the sham group
(ANCOVA adjusted mean difference -12.3 mm; 95% con-
fidence interval -22.4 to -2.2). This difference was statisti-
cally significant (P = 0.017). Although there were small
differences between groups with respect to improvements
in the Foot Health Status Questionnaire none were statis-
tically significant (Table 2). These results are presented
graphically in Figure 3.
In the taping group, 13 participants (28%) experienced
adverse events while no events were reported by the sham
group. Adverse events were described as taping too tight
(n = 4), a new pain in lower limb (n = 5) and allergic reac-
Table 1: Baseline characteristics of participants. Values are means (± standard deviation) unless stated otherwise.
Variable Taping (n = 46) Sham (n = 46)
Age in years 51.3 (± 13.5) 49.2 (± 13.8)
BMI in kg/m2 30.0 (± 4.8) 30.6 (± 6.5)
Self reported hours on feet 8.8 (± 3.8) 7.5 (± 2.8)
Period of symptoms in months – median (range) 9 (3 to 240) 10 (2 to 97)
No. of women (%) 28 (60.9) 27 (58.7)
Foot affected
Right – No. (%) 10 (21.7) 12 (26.1)
Left – No. (%) 7 (15.2) 12 (26.1)
Both feet – No. (%) 29 (63.0) 22 (47.8)
Foot Posture*
Right 3.2 (± 2.1) 2.9 (± 2.2)
Left 3.1 (± 2.1) 2.9 (± 2.2)
Ankle range of motion in degrees§
Right 22.8 (± 7.9) 23.4 (± 6.4)
Left 24.9 (± 7.5) 24.4 (± 6.6)
'First-step' pain† 71.4 (± 19.8) 72.0 (± 20.0)
Foot painΨ 35.5 (± 20.8) 35.8 (± 20.1)
Foot functionΨ 54.3 (± 25.7) 60.6 (± 26.6)
General foot healthΨ 30.7 (± 26.9) 27.0 (± 26.3)
* The Foot Posture Index-6 has a score range of -12 to 12 with negative values for signs of foot supination and positive values for signs of foot 
pronation. Normal foot posture is reported to be between 0 to 5[28]
§ Ankle range of motion measured using the lunge test[29] a measure of ankle dorsiflexion
† Measured using a Visual Analogue Scale (0 to 100 mm)
Ψ Measured using the Foot Health Status Questionnaire (0 to 100)BMC Musculoskeletal Disorders 2006, 7:64 http://www.biomedcentral.com/1471-2474/7/64
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tion to the tape (n = 4). Adverse events were recorded as
mild (n = 5), moderate (n = 5) or severe (n = 3) in nature.
Five participants removed their tape before their final
appointment due to adverse events (three due to allergic
reactions and two due to tightness of the tape). Upon tape
removal, all adverse events resolved.
With respect to blinding, thirty-eight participants (83%)
in the taping group correctly identified their treatment
group compared with three participants (7%) in the sham
group. Five participants (11%) in the taping group were
uncertain which treatment they received, compared with
twenty participants (43%) in the sham group and three
participants (7%) the taping group and twenty-three par-
ticipants (50%) in the sham group incorrectly identified
their treatment group. The index to assess the success of
blinding[20] was computed to be 0.61 (bootstrap 95%
confidence interval 0.54 to 0.69). The value of 0.61 repre-
sents a statistically significant amount of blinding beyond
that expected by chance and demonstrates an acceptable
level of blinding for a trial using sham ultrasound.
Discussion
The results demonstrate that low-Dye taping produces a
small but statistically significant beneficial effect on 'first-
step' pain compared with sham ultrasound. The difference
of 12.3 mm on the 100 mm Visual Analogue Scale is
greater than the 9 to 10 mm difference thought to be clin-
ically important [16,21-23]. No significant differences
between groups were found for improvements in foot
pain, foot function and general foot health as measured
using the Foot Health Status Questionnaire at one week.
One reason for this trial finding a statistically significant
improvement only for 'first-step' pain with taping could
be due to it being the symptom of plantar heel pain that
is notable to patients. It is well known that this symptom
– that is sharp pain when first getting out of bed in the
morning – is characteristic of plantar heel pain and for
this reason it was one of the inclusion criteria in this trial.
Alternatively, the Foot Health Status Questionnaire may
not have been sensitive or specific enough to corroborate
with the improvement detected in 'first-step' pain (meas-
ured explicitly using a 100 mm Visual Analogue Scale).
This is the first randomised trial to evaluate a foot taping
technique for plantar heel pain. Two non-randomised tri-
Participant flow diagram Figure 2
Participant flow diagram.
Participants randomised
(n=92)
Included in analysis (n=46)
Completed treatment (n=46)
Lost to follow-up (n=0)
Baseline (n=46)
TAPING group
Low-Dye taping and 
sham ultrasound
Included in analysis (n=46)
Completed treatment (n=46)
Lost to follow-up (n=0)
Baseline (n=46)
Excluded (n=41)
Did not meet inclusion criteria (n=39)
Refused to participate (n=2)
Assessed for eligibility
(n=133)
SHAM group
Sham ultrasound only
Table 2: Outcomes at follow-up.
Outcome measure Group Adjusted mean 
difference (95% CI)
P-value
Taping – mean (SD) Sham – mean (SD)
'First-step' pain* 41.4 (± 28.5) 54.0 (± 24.8) -12.3 (-22.4 to -2.2) 0.017
Foot painΨ 60.0 (± 22.0) 53.5 (± 21.0) 6.6 (-1.7 to 14.8) 0.117
Foot functionΨ 72.0 (± 21.9) 70.9 (± 25.0) 4.8 (-2.5 to 12.2) 0.193
General foot healthΨ 43.2 (± 27.7) 41.2 (± 27.4) -0.6 (-9.1 to 7.9) 0.885
* Measured using a Visual Analogue Scale (0 to 100 mm – 0 is no pain and 100 is the worst pain)
Ψ Measured using the Foot Health Status Questionnaire (0 to 100 – 0 is the worst foot health and 100 is the best foot health)
Note: The Foot Health Status Questionnaire is 'reverse-scored' compared to the Visual Analogue Scale. In the results above, the negative 
ANCOVA adjusted mean difference for the comparison of 'first-step' pain favours taping because it has lower pain. In comparison, a positive score 
for the Foot Health Status Questionnaire domains favours the taping group.BMC Musculoskeletal Disorders 2006, 7:64 http://www.biomedcentral.com/1471-2474/7/64
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als have previously examined low-Dye taping for plantar
heel pain[12,13]. A small case series [12] of only eight
participants reported a beneficial effect from the tape
although no outcome data were presented. A larger (n =
105) trial[13] reported a 32 mm reduction in pain (95%
confidence interval 24 to 40) on a 100 mm Visual Ana-
logue Scale in a taping group compared to a control
group; however the intervention was not randomly allo-
cated. The results of the current randomised trial also
reflect a 30 mm reduction in pain for the taping group;
however the sham group experienced a 19 mm reduction
in pain as well. Therefore, our randomised trial suggests
that approximately 19 mm of reduction in the non-ran-
domised trial could have been due to confounding factors
such as the placebo or Hawthorne effects.
Participant characteristics in this trial were similar to sam-
ples in previous heel pain trials [8,13,24,25]. Participants
were primarily middle-aged women who were overweight
and spent the majority of the day on their feet. Likewise,
participants also presented with relatively chronic symp-
toms.
The majority of adverse events in this trial were described
by participants as short-lived and mild to moderate in
intensity. Five participants removed the tape prior to fol-
low-up due to an adverse event. Three were due to allergic
reactions to the tape and two due to tightness of the tape;
all resolved following tape removal. Such minor events
could be minimised with the use of hypoallergenic tape
and caution in applying tape to reduce tightness.
Limitations
The findings of this trial need to be viewed in light of
some limitations. "Firstly, recruiting volunteers from
advertisements in local community newspapers may
include participants who are systematically different from
those recruited from amongst patients currently seeking
care. However, as discussed previously, the characteristics
of participants in our trial are similar to participants in
other plantar fasciitis trials [8,13,24,25].
Secondly, we only treated the worst foot in bilateral cases
to avoid collecting paired data, where outcome data from
left and right feet may be highly correlated[26]. Partici-
pants were asked to concentrate on the symptoms relating
to the treated foot for all outcomes and this may have led
to an erroneous estimate of the treatment effect if partici-
pants were unable to separate the symptoms from the
other unrelated foot. Future trials should consider includ-
ing only unilateral cases or treat both feet and collect the
data from the two feet as one independent sample using
outcomes such as the Foot Health Status Questionnaire.
Thirdly, the evidence from this trial is for one particular
low-Dye taping technique only. Numerous modifications
have been described and future trials may also wish to
examine more aggressive taping techniques, such as the
technique described by Lange, Chipchase & Evans[27].
These techniques use greater amounts of tape in an
attempt to further decrease collapse of the longitudinal
arch and subsequent strain on the plantar fascia.
Finally, the trial specifically examined the effect of taping
over a one week period as the technique is usually only
used as a short-term treatment for plantar heel pain; gen-
erally while a patient is awaiting fabrication of a longer-
term treatment such as foot orthoses[8]. It would be of
interest to evaluate the effectiveness of regular application
of the tape over a longer period to investigate whether an
extended application has a long-term effect. This may
obviate the need to institute more expensive long-term
treatments such as foot orthoses; although the risk of a
higher incidence of adverse events may not make this
worthwhile.
Forest plot of adjusted mean differences with 95% confi- dence intervals for outcomes Figure 3
Forest plot of adjusted mean differences with 95% confi-
dence intervals for outcomes.
Note: 'First-step' pain measured in mm on a Visual Analogue Scale (0 to 100mm).
Foot pain, foot function and general foot health measured on the Foot Health Status 
Questionnaire (0 to 100 scale).  For illustrative purposes, ‘first-step’ pain has been
converted to a positive score so the direction of effect favouring taping is the same for 
all outcomes.BMC Musculoskeletal Disorders 2006, 7:64 http://www.biomedcentral.com/1471-2474/7/64
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Conclusion
Low-Dye taping is effective for the short-term treatment of
the common symptom of 'first-step' pain in patients with
plantar heel pain. The taping technique used in this trial
was associated with mild to moderate short-lived adverse
events. Low-Dye taping could be used as an inexpensive
short-term treatment for plantar heel pain while patients
wait for longer-term treatments, such as foot orthoses.
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